How to administer norepinephrine for hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Administration for Hypotension

For hypotension management, norepinephrine should be administered intravenously at an initial rate of 0.1-0.5 mcg/kg/min, titrated to maintain a target mean arterial pressure (MAP) of 65 mmHg, with continuous hemodynamic monitoring. 1

Preparation and Administration

Standard Preparation

  • For infusion pump use:

    • Add 1 mg (1 mL) of norepinephrine to 100 mL of normal saline to create a 1:100,000 solution (10 mcg/mL)
    • Initial rate: 30-100 mL/hr (5-15 mcg/min), titrated based on clinical response 2
  • Alternative preparation (microdrop method):

    • Add 1 mg (1 mL) of norepinephrine to 250 mL of D5W to yield a 4.0 mcg/mL concentration
    • Infuse at 1-4 mcg/min (15-60 drops/min with microdrop apparatus)
    • Maximum rate: 10 mcg/min for adults and adolescents 2

Pediatric Dosing

  • Recommended dose: 0.01 mg/kg (0.1 mL/kg of a 1:10,000 solution; maximum 0.3 mg) 2
  • Alternative "rule of 6" dosing: 0.6 × weight (kg) = mg diluted to total 100 mL saline; then 1 mL/hr delivers 0.1 mcg/kg/min 2

Administration Route and Monitoring

Central vs. Peripheral Administration

  • Traditionally administered through central venous catheters (CVCs)
  • Recent evidence suggests peripheral administration may be safe for:
    • Low doses (<0.5 mcg/kg/min)
    • Short duration (<24 hours)
    • When using proper protocols with vigilant monitoring 3, 4

Required Monitoring

  • Continuous arterial blood pressure monitoring is essential 1
  • Check IV site every 2 hours for signs of extravasation 3
  • Monitor tissue perfusion markers (lactate levels, urine output, capillary refill) 1
  • Electrocardiographic monitoring when available 2

Clinical Response Management

Inadequate Response

  • If inadequate response after 10 minutes:
    • Escalate norepinephrine dose (doubling the bolus dose) 2
    • Consider starting continuous infusion if more than three boluses needed 2
    • Add vasopressin (up to 0.03 U/min) or epinephrine as second agents 2
    • Consider additional fluid administration up to 20-30 mL/kg 2

Refractory Hypotension

  • Add norepinephrine infusion (0.05-0.5 mcg/kg/min) 2
  • Consider vasopressin (1-2 IU bolus with or without infusion at 2 units/hr) 2
  • For patients on beta-blockers: add IV glucagon (1-2 mg) 2
  • Consider extracorporeal life support in extreme cases 2

Complications and Management

Extravasation

  • If extravasation occurs, infiltrate the site with 5-10 mg phentolamine diluted in 10-15 mL saline 1
  • Monitor for tissue necrosis, which is a serious complication 1

Other Potential Complications

  • Supraventricular arrhythmias (7.25 times higher risk compared to vasopressin) 1
  • Increased myocardial oxygen consumption (caution in coronary artery disease) 1
  • Decreased cardiac output due to increased afterload 1
  • Digital ischemia from peripheral vasoconstriction 1

Special Considerations

Drug Interactions

  • Never mix with alkaline solutions like sodium bicarbonate (leads to inactivation) 1

Contraindications and Cautions

  • Relative contraindication in hypovolemia - correct volume status first 1
  • Use with caution in patients with ischemic heart disease 1
  • Avoid in patients with mesenteric or peripheral vascular thrombosis 1

By following these guidelines for norepinephrine administration, you can effectively manage hypotension while minimizing the risk of adverse effects and complications.

References

Guideline

Cardiovascular Support Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.